Effect Nitrous Oxide On Acute Postoperative Pain and Opioid Consumption and Chronic Pain After Inguinal Hernia Repair Surgery
Study Details
Study Description
Brief Summary
The study is prospective and double blind. In the clinic, patients undergoing inguinal hernia surgery that meet the criteria for inclusion into the study and agreed to participate in the study will be randomized into two groups. In the first group of patients will receive Nitrous Oxide and In the second group of patients will receive oxygen during the general anesthesia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Nitrous oxide Subjects will receive General anesthesia with Nitrous Oxide. |
Drug: Nitrous Oxide
Nitrous Oxide, 70%, O2 30%) 1-5 L, Sevoflurane 1-2%, ETCO2: 32-35 mmHg.
|
Placebo Comparator: Oxygen Subjects will receive General anesthesia with oxygen. |
Other: oxygen
Subjects will receive General anesthesia: (Air, 70%, O2 30%) 1-5 L, Sevoflurane 1-2%, ETCO2: 32-35 mmHg.
|
Outcome Measures
Primary Outcome Measures
- Nitrous oxide and chronic pain [30 days post operative]
The effect of 70% N20/30% O2 on post inguinal hernia repair procedure in prevention of chronic pain.
- Nitrous oxide and opioid consumption [4 hours after surgery]
The effect of 70% N20/30% O2 on post inguinal hernia repair procedure in decrease in opioid consumption.
Secondary Outcome Measures
- smoking and post operative pain [4 hours after surgery]
The effect of active smoking to increase post operative acute pain.
- smoking and chronic pain [30 days post operative]
The effect of active smoking and chronic pain
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 to 65 years old at time of the first procedure
-
American Society of Anesthesiologists physical status I or II
-
Inguinal hernia repair surgery undergoing the general anesthesia
Exclusion Criteria:
-
Neuropathic disease
-
Chronic opioid users
-
Contraindication for Nitrous Oxide receive
-
Consent will not be obtained patient
-
Psychiatric disorders
-
Current or recent drug abuse (within past 6 months).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Gulhane Military Medical Academy Hospital | Etlik | Ankara | Turkey | 06018 |
Sponsors and Collaborators
- The Cleveland Clinic
Investigators
- Principal Investigator: Alparslan Turan, M.D., The Cleveland Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 10/1539